NPASS Compound

Structure

NPC301408 OpenBabel06302215392D 36 40 0 0 1 0 0 0 0 0999 V2000 5.5981 -3.2321 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.7321 -2.7321 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.8660 -3.2321 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.0000 -2.7321 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 2.1340 -3.2321 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.2679 -2.7321 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.4019 -3.2321 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.4641 -2.7321 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.3301 -3.2321 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.3301 -4.2321 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.1962 -4.7321 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -0.4641 -4.7321 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 0.4019 -4.2321 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.2679 -4.7321 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.1340 -4.2321 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.0000 -4.7321 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 3.8660 -4.2321 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.0000 -1.7321 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 2.5000 -0.8660 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.8660 -1.2321 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.7321 -1.7321 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.0000 -1.7321 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.5000 -0.8660 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.5000 -0.8660 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.0000 -1.7321 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.0000 -1.7321 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.5000 -2.5981 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.5000 -2.5981 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.0000 -1.7321 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.0000 -1.7321 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -2.5000 -0.8660 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -1.5000 -0.8660 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.0000 -0.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.0000 -0.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.5000 0.8660 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1.5000 0.8660 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 0 0 0 2 21 1 0 0 0 0 2 3 2 0 0 0 0 3 4 1 0 0 0 0 4 5 1 6 0 0 0 4 18 1 0 0 0 0 5 15 2 0 0 0 0 5 6 1 0 0 0 0 6 7 2 0 0 0 0 7 13 1 0 0 0 0 7 8 1 0 0 0 0 8 9 2 0 0 0 0 9 10 1 0 0 0 0 10 11 2 0 0 0 0 10 12 1 0 0 0 0 12 13 1 0 0 0 0 13 14 2 0 0 0 0 14 15 1 0 0 0 0 15 16 1 0 0 0 0 16 17 1 0 0 0 0 18 19 1 6 0 0 0 18 20 1 0 0 0 0 18 22 1 0 0 0 0 20 21 1 0 0 0 0 22 23 2 0 0 0 0 23 24 1 0 0 0 0 24 34 2 0 0 0 0 24 25 1 0 0 0 0 25 26 2 0 0 0 0 26 32 1 0 0 0 0 26 27 1 0 0 0 0 27 28 2 0 0 0 0 28 29 1 0 0 0 0 29 30 2 0 0 0 0 29 31 1 0 0 0 0 31 32 1 0 0 0 0 32 33 2 0 0 0 0 33 34 1 0 0 0 0 34 35 1 0 0 0 0 35 36 1 0 0 0 0 M END $$$$

Physi-Chem Properties

Molecular Weight:	484.19
Volume:	505.758
LogP:	5.567
LogD:	3.829
LogS:	-6.759
# Rotatable Bonds:	5
TPSA:	78.88
# H-Bond Aceptor:	6
# H-Bond Donor:	0
# Rings:	5
# Heavy Atoms:	6

MedChem Properties

QED Drug-Likeness Score:	0.239
Synthetic Accessibility Score:	3.91
Fsp3:	0.267
Lipinski Rule-of-5:	Accepted
Pfizer Rule:	Accepted
GSK Rule:	Rejected
BMS Rule:	0
Golden Triangle Rule:	Accepted
Chelating Alert:	0
PAINS Alert:	0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:	-4.986
MDCK Permeability:	1.3842023690813221e-05
Pgp-inhibitor:	0.998
Pgp-substrate:	0.932
Human Intestinal Absorption (HIA):	0.006
20% Bioavailability (F20%):	0.968
30% Bioavailability (F30%):	1.0

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):	0.003
Plasma Protein Binding (PPB):	82.0096206665039%
Volume Distribution (VD):	0.577
Pgp-substrate:	12.044926643371582%

ADMET: Metabolism

CYP1A2-inhibitor:	0.372
CYP1A2-substrate:	0.962
CYP2C19-inhibitor:	0.784
CYP2C19-substrate:	0.24
CYP2C9-inhibitor:	0.792
CYP2C9-substrate:	0.936
CYP2D6-inhibitor:	0.514
CYP2D6-substrate:	0.908
CYP3A4-inhibitor:	0.877
CYP3A4-substrate:	0.87

ADMET: Excretion

Clearance (CL):	8.163
Half-life (T1/2):	0.09

ADMET: Toxicity

hERG Blockers:	0.234
Human Hepatotoxicity (H-HT):	0.615
Drug-inuced Liver Injury (DILI):	0.955
AMES Toxicity:	0.053
Rat Oral Acute Toxicity:	0.516
Maximum Recommended Daily Dose:	0.961
Skin Sensitization:	0.041
Carcinogencity:	0.704
Eye Corrosion:	0.003
Eye Irritation:	0.155
Respiratory Toxicity:	0.933

Download Data

Data Type	Select
General Info & Identifiers & Properties
Structure MOL file
Source Organisms
Biological Activities
Similar NPs/Drugs

Natural Product: NPC301408

Natural Product ID:	NPC301408
*Common Name:**	SWGAQLQAABDHGT-UUXPXKILSA-N
IUPAC Name:	n.a.
Synonyms:
Standard InCHIKey:	SWGAQLQAABDHGT-UUXPXKILSA-N
Standard InCHI:	InChI=1S/C30H28O6/c1-18-9-11-30(2,12-10-21-14-19-5-7-28(31)35-25(19)16-24(21)33-3)23(13-18)22-15-20-6-8-29(32)36-26(20)17-27(22)34-4/h5-8,10,12-17,23H,9,11H2,1-4H3/b12-10+/t23-,30-/m1/s1
SMILES:	CC1=C[C@H](c2cc3ccc(=O)oc3cc2OC)[C@](C)(CC1)/C=C/c1cc2ccc(=O)oc2cc1OC
Synthetic Gene Cluster:	n.a.
ChEMBL Identifier:	n.a.
PubChem CID:	n.a.
Chemical Classification:**	CHEMONTID:0000000 [Organic compounds] [CHEMONTID:0000261] Phenylpropanoids and polyketides [CHEMONTID:0000145] Coumarins and derivatives

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

Species Source

Organism ID	Organism Name	Taxonomy Level	Family	SuperKingdom	Isolation Part	Collection Location	Collection Time	Reference
NPO24827	Caragana conferta	Species	Fabaceae	Eukaryota	n.a.	whole plant	n.a.	PMID[19336940]
NPO24870	Campanula patula	Species	Campanulaceae	Eukaryota	n.a.	n.a.	n.a.	Database[UNPD]
NPO24827	Caragana conferta	Species	Fabaceae	Eukaryota	n.a.	n.a.	n.a.	Database[UNPD]
NPO24994	Thladiantha dubia	Species	Cucurbitaceae	Eukaryota	n.a.	n.a.	n.a.	Database[UNPD]
NPO21354	Juniperus cedrus	Species	Cupressaceae	Eukaryota	n.a.	n.a.	n.a.	Database[UNPD]
NPO23770	Artemisia gmelini	Species	Asteraceae	Eukaryota	n.a.	n.a.	n.a.	Database[UNPD]
NPO23813	Ardisia floribunda	Species	Primulaceae	Eukaryota	n.a.	n.a.	n.a.	Database[UNPD]
NPO25040	Tellina nitida	Species	Tellinidae	Eukaryota	n.a.	n.a.	n.a.	Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
☉ UNPD: Universal Natural Products Database [PMID: 23638153].
☉ StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
☉ TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
☉ TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
☉ TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
☉ TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
☉ HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
☉ MetaboLights: a metabolomics database [PMID: 27010336].
☉ FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

NP Quantity Composition/Concentration

Organism ID	NP ID	Organism Material Preparation	Organism Part	NP Quantity (Standard)	NP Quantity (Minimum)	NP Quantity (Maximum)	Quantity Unit	Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
☉ DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
☉ PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
☉ FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

Biological Activity

Target ID	Target Type	Target Name	Target Organism	Activity Type	Activity Relation	Value	Unit	Reference

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

● The left chart: Distribution of similarity level between NPC301408 and all remaining natural products in the NPASS database.
● The right table: Most similar natural products (Tc>=0.56 or Top200).

range	Tanimoto Coefficient
0-0.1	476
0.1-0.2	1739
0.2-0.3	3920
0.3-0.4	9195
0.4-0.5	9647
0.5-0.6	4660
0.6-0.7	5963
0.7-0.8	5390
0.8-0.85	1319
0.85-0.9	321
0.9-0.95	67
0.95-1	0

Similarity Score	Similarity Level	Natural Product ID

Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

● The left chart: Distribution of similarity level between NPC301408 and all drugs/candidates.
● The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

range	Tanimoto Coefficient
0-0.1	418
0.1-0.2	955
0.2-0.3	1586
0.3-0.4	2663
0.4-0.5	2044
0.5-0.6	1013
0.6-0.7	316
0.7-0.8	117
0.8-0.85	30
0.85-0.9	8
0.9-0.95	0
0.95-1	0

Similarity Score	Similarity Level	Drug ID	Developmental Stage

Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
☉ A: chemistry similarity;
☉ B: biological targets similarity;
☉ C: networks similarity;
☉ D: cell-based bioactivity similarity;
☉ E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity

B: biological targets similarity

C: networks similarity

D: cell-based bioactivity similarity

E: similarity based on clinical data